
|Articles|January 23, 2018
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
CDC Adolescents, Children, & Adult Immunization Schedule: 2025 Update
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
PCV21-Unique Serotypes Most Prevalent in US Adults With Pneumococcal Disease
5














































































































































































































